Brief: Anixa Biosciences Receives Notice Of Allowance From U.S. Patent And Trademark Office
09/04/2025 13:21
April 9 (Reuters) - Anixa Biosciences Inc ANIX.O: ANIXA BIOSCIENCES RECEIVES NOTICE OF ALLOWANCE FROM U.S. PATENT AND TRADEMARK OFFICE FOR PATENT COVERING BREAST CANCER VACCINE TECHNOLOGY Source text: ID:nPn2GC99sa Further company coverage: ANIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine